[Federal Register Volume 83, Number 210 (Tuesday, October 30, 2018)]
[Notices]
[Page 54613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23695]



[[Page 54613]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before December 31, 2018.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated his 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been delegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on June 
14, 2018, Sigma Aldrich Research, 1-3 Strathmore Road, Natick, 
Massachusetts 01760-2447 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
Lysergic acid diethylamide.........            7315  I
3,4-Methylenedioxymethamphetamine..            7405  I
Dimethyltryptamine.................            7435  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
Heroin.............................            9200  I
Normorphine........................            9313  I
Norlevorphanol.....................            9634  I
Amphetamine........................            1100  II
Nabilone...........................            7379  II
Cocaine............................            9041  II
Codeine............................            9050  II
Ecgonine...........................            9180  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Methadone..........................            9250  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Levo-alphacetylmethadol............            9648  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.

    Dated: October 11, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-23695 Filed 10-29-18; 8:45 am]
 BILLING CODE 4410-09-P